REQUEST A DEMO
Total
USD $0.00
Search more companies

Drogueria La Espanola Uno Sas (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Drogueria La Espanola Uno Sas Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Drogueria La Espanola Uno Sas is based in Colombia, with the head office in Floridablanca. The enterprise currently operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on February 06, 2012. 14 (2022) employees currently work for Drogueria La Espanola Uno Sas. The company’s latest financial report indicates a net sales revenue drop of 35.27% in 2021. Its’ total assets recorded a negative growth of 16.41%. In 2021, Drogueria La Espanola Uno Sas’s net profit margin decreased by 0.29%.

Headquarters
Transversal 154 # 150 - 221 Oficina E 4 - 1 Piso 4
Floridablanca; Santander;

Contact Details: Purchase the Drogueria La Espanola Uno Sas report to view the information.

Basic Information
Total Employees:
Purchase the Drogueria La Espanola Uno Sas report to view the information.
Outstanding Shares:
Purchase the Drogueria La Espanola Uno Sas report to view the information.
Incorporation Date:
February 06, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Drogueria La Espanola Uno Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-35.27%
Total operating revenue
-35.27%
Net Profit (Loss) for the Period
-43.91%
Total assets
-16.41%
Total equity
8.05%
Net Profit Margin
-0.29%
Return on Equity (ROE)
-6.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?